Mode
Text Size
Log in / Sign up

Report estimates proportion of U.S. adults with HIV not adhering to medication due to costReport examines how often U.S. adults with HIV skip medications due to cost

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: Observational report on HIV medication nonadherence due to cost lacks reported results.

This observational report examined the proportion of U.S. adults with HIV infection who did not adhere to any prescribed medication due to costs during the period from May 2016 to June 2017. The study population consisted of U.S. adults with human immunodeficiency virus, though the specific sample size was not reported. No intervention, comparator, or specific setting details beyond the United States were provided.

The primary outcome was the proportion of this population who did not adhere to medication due to cost. However, the abstract does not report any main results, including the estimated proportion, absolute numbers, effect sizes, p-values, or confidence intervals. The direction of any association was also not reported. No secondary outcomes were mentioned.

No safety or tolerability data regarding adverse events, serious adverse events, or discontinuations were reported. The abstract did not include information on study limitations, funding sources, or conflicts of interest. The practice relevance of the findings was not specified.

Given the observational design, any findings would represent associations rather than causation. The complete absence of reported quantitative results in the abstract significantly limits interpretation. Clinicians should await the full publication for specific estimates and methodological details before drawing conclusions about cost-related nonadherence in this population.

A report examined how often adults living with HIV in the United States do not take their prescribed medications because they cannot afford them. The study looked at data from May 2016 to June 2017. The goal was to understand the scale of this problem, which can affect health outcomes.

The report focused on U.S. adults diagnosed with human immunodeficiency virus (HIV). The main finding the report aimed to provide was the estimated proportion of these individuals who could not stick to their medication plan due to cost. However, the specific number or percentage was not reported in the available summary of the findings.

This was an observational report, meaning it describes a situation but cannot prove what causes it. We do not know from this summary if the problem got better or worse over time, or what specific factors are involved. No information about safety or side effects from not taking medication was provided.

Readers should understand this is a report highlighting an important issue—medication affordability for people with HIV. The key point is that cost can be a barrier to treatment, which is a known challenge. However, without the specific results, we cannot say how common this problem is based on this report alone.

What this means for you:
A report looked at HIV medication costs as a barrier, but specific findings on how many people are affected were not shared.

Study Details

EvidenceLevel 5
PublishedDec 2019
View Original Abstract ↓
This report estimates the proportion of U.S. adults with human immunodeficiency virus who did not adhere to medication due to cost during May 2016-June 2017.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.